A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

PHASE4CompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
HIV Infections
Interventions
DRUG

Emtricitabine 200mg - Tenofovir 300mg

1 tablet once daily for 96 weeks

DRUG

Abacavir 600mg - Lamivudine 300mg

1 tablet once daily for 96 weeks

Trial Locations (31)

2010

407 Doctors, Sydney

Albion Street Centre, Sydney

Holdsworth House General Practice, Sydney

St. Vincent's Hospital, Sydney

Taylor Square Private Clinic, Sydney

2031

Prince of Wales Hospital, Sydney

2065

Clinic 16, Royal North Shore Hospital, Sydney

2134

Burwood Road Practice, Sydney

2145

Westmead Hospital, Sydney

2170

Liverpool Health Service, Sydney

2304

John Hunter Hospital, Newcastle

2480

Lismore Sexual Health Clinic - Northen Rivers Area Health Service, Lismore

2481

Holdsworth House General Practice - Byron Bay, Byron Bay

3004

The Alfred Hospital, Melbourne

3053

Carlton Clinic, Melbourne

Melbourne Sexual Health Centre, Melbourne

3141

Prahran Market Clinic, Melbourne

3168

Monash Medical Centre, Melbourne

3182

The Centre Clinic, Melbourne

3403

Royal Melbourne Hospital, Melbourne

4002

QLD Health - AIDS Medical Unit, Brisbane

4029

Royal Brisbane and Women's Hospital, Brisbane

4101

Gladstone Road Medical Centre, Brisbane

4220

Gold Coast Sexual Health Clinic, Miami

4560

Clinic 87, Nambour Hospital, Nambour

4870

Doll's House Clinic - Cairns Base Hospital, Cairns

5000

Royal Adelaide Hospital, Adelaide

The Care and Prevention Programme - Adelaide University, Adelaide

5042

Flinders Medical Centre, Adelaide

6000

Royal Perth Hospital, Perth

6160

Fremantle Hospital, Fremantle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kirby Institute

OTHER_GOV